Economic and medical benefits of ultrasound screenings for gallstone disease

doi:10.3748/wjg.v21.i11.3337

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6828)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

401

WORD

307

HTML

2856

Figures (1-1)

274

Tables (1-3)

232

Sum=4070

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1254

Download

1504

Sum=2758

Mar 21, 2015 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Mar 21, 2015; 21(11): 3337-3343
Published online Mar 21, 2015. doi: 10.3748/wjg.v21.i11.3337

Table 2 Cost-effectiveness analysis and cost-utility analysis for different screening programs for gallstone disease during 10 years follow-up

Screening strategy	Cost (NTD)	Effectiveness(life-years gained)	Cost/effectiveness (NTD)	ICER (compared to control group)	Utility (QALY)	Cost/utility(NTD)	ICUR (compared to control group)
Annual	199856	5.1146	39076	Dominate¹	4.9075	40725	Dominate¹
Biennial	215231	3.7071	58059	Dominate¹	3.3180	64868	Dominate¹
3-yearly	253908	3.5183	72168	Dominate¹	3.0037	84532	Dominate¹
4-yearly	331477	3.1724	104488	Dominate¹	2.9873	110962	Dominate¹
5-yearly	368002	2.8990	126941	Dominate¹	2.5906	142053	Dominate¹
Control group	508117	2.5731	197473	-	2.5033	202979	-

¹Any screening program was more cost-effective than no program. ICER: Incremental cost-effectiveness ratio; ICUR: Incremental cost-utility ratio; NTD: New Taiwan dollars; QALY: Quality-adjusted life-year.

Citation: Shen HJ, Hsu CT, Tung TH. Economic and medical benefits of ultrasound screenings for gallstone disease. World J Gastroenterol 2015; 21(11): 3337-3343
URL: https://www.wjgnet.com/1007-9327/full/v21/i11/3337.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i11.3337